Clinical Trials in Progress

NEVORA

Advanced Bio-Regeneration
Minimal Pain, Maximum Efficacy.

NEVORA activates the skin's self-regeneration power using high-purity PN, restoring density and elasticity from deep within the dermis.

* The contents herein are based on the properties of the raw material (PN). The final product efficacy is currently under clinical trial.

Mechanism of Action

DNA Synthesis via Salvage Pathway

NEVORA utilizes Polynucleotide (PN) to activate the 'Salvage Pathway'. Unlike artificial stimulation, this mechanism supplies nucleotides directly to the skin cells, facilitating rapid DNA synthesis and tissue regeneration.

Tissue Repair: Activates dermal fibroblasts.
Collagen Synthesis: Promotes density improvement.
Safe Regeneration: Biocompatible DNA fragments.

* Based on the mechanism of Polynucleotide (PN). Clinical trials underway.

Clinical Efficacy Data

High-purity PN has shown significant improvements in preliminary studies.

Wound Recovery

86.15%

Dermal cell wounds closed more than 86% in controlled tests.

Lifting Effect

78.50%

Improved skin density leading to significant lifting effects.

Moisturizing

Pore Tightening

Skin Tone

Elasticity

* Data Source: In-vitro tests on PN ingredient properties. Product efficacy currently under clinical trial.

Why NEVORA?

Overcoming the Limits of Traditional PN

	Standard PN	NEVORA
Pain Level	High (Stinging)	Significantly Reduced
pH Balance	Acidic	Optimal Physiological pH
Experience	Uncomfortable	Smooth & Gentle

* Comparative analysis based on formulation technology. Clinical verification in progress.

Frequently Asked Questions

We recommend 3 to 4 sessions at 2-3 week intervals for optimal bio-regeneration and long-lasting results. (Protocol under clinical refinement).

NEVORA has minimal downtime. Mild swelling or bumps may appear but typically subside within 24 hours.

Yes, PN is biocompatible and derived from salmon DNA, which is very similar to human DNA, minimizing immune reactions.